Related Experiment Video
Updated: Jul 11, 2026

One-step Negative Chromatographic Purification of Helicobacter pylori Neutrophil-activating Protein Overexpressed in Escherichia coli in Batch Mode
Published on: June 18, 2016
How should Helicobacter pylori negative patients be managed?
V Stanghellini1, C Tosetti, R De Giorgio
1Department of Internal Medicine and Gastroenterology, University of Bologna, Policlinico S. Orsola-Malpighi, Via Massarenti 9, 40138 Bologna, Italy.
Dyspepsia, a common epigastric symptom complex, often lacks a clear cause. While Helicobacter pylori eradication benefits few, managing H. pylori-negative patients by predominant symptom shows promise, requiring further study.
Area of Science:
- Gastroenterology
- Digestive Health
Background:
- Dyspepsia presents with epigastric symptoms, distinct from but overlapping with GORD and IBS.
- While Helicobacter pylori causes ulcers, its direct causal role in dyspepsia symptoms is unproven, and eradication benefits only a minority.
- Idiopathic dyspepsia is common, with H. pylori infection being a frequent comorbidity.
Purpose of the Study:
- To evaluate the effectiveness of managing H. pylori-negative dyspepsia based on predominant symptoms.
- To explore if symptom-based stratification identifies distinct pathophysiological subgroups and treatment responses.
Main Methods:
- Review of experimental data and recent proposals for managing H. pylori-negative dyspepsia.
- Consideration of clinical presentation and predominant symptoms for patient subgrouping.
Main Results:
- H. pylori eradication does not improve symptoms in most dyspeptic patients.
- Managing H. pylori-negative patients based on predominant symptoms is a proposed strategy.
- This approach may help identify distinct subgroups with different underlying conditions and treatment responses.
Conclusions:
- Further well-designed prospective studies are needed to validate symptom-based management for H. pylori-negative dyspepsia.
- Verifying the cost-effectiveness of this approach is crucial for clinical implementation.
More Related Videos
06:40Quantitative Polymerase Chain Reaction (qPCR)-Based Rapid Diagnosis of Helicobacter pylori Infection and Antibiotic Resistance
Published on: July 28, 2023
05:23Gastric Mucosa Quantitative Polymerase Chain Reaction Analysis for Detecting Helicobacter pylori and Antibiotic Resistance
Published on: March 7, 2025
Related Concept Videos
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
Gastritis III: Clinical Manifestations and Management
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
Peptic Ulcer
Gastritis II: Pathophysiology